Nanoparticles in 21st Century Medicine
A special issue of Micromachines (ISSN 2072-666X). This special issue belongs to the section "B3: Nanoparticles in Biomedicine".
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 539
Special Issue Editors
2. Center for Healthy Longevity, National University Health System, Singapore 117456, Singapore
Interests: nanotechnology; nanoparticles; neuroscience; geroscience; stem cells
Interests: organic probes and upconversion luminescent materials for sensing and bioimaging; point-of-care diagnostics and cancer therapy
Special Issue Information
Dear Colleagues,
Developments in nanoparticles design have seen the emergence of engineered nanoparticles capable of sieving across biological barriers for targeted drug delivery, or even genome editing. Most notably, the rolling out of mRNA vaccines during the COVID-19 pandemic is yet another sign of major nanotechnological breakthrough in the 21st century medicine. mRNA by itself is highly susceptible to degradation in the body. Therefore, engineered nanoparticles such as liposome carriers can now achieve the aim of maintaining nuclei acid’s stability, when delivered in the body. Furthermore, the feasibility of targeted drug delivery is now achievable in localized chemotherapy in liver cancer, conceived from the idea of using nanoparticles as carriers for chemotherapeutic drugs. With an ever-growing pipeline of nanoparticles being approved by the FDA for a variety of pathological therapeutics, there is emerging attention on the next stage of nanoparticles clinical application. Accordingly, this issue will comprehensively cover a collection of research papers, short communications and review articles that focus on novel and recent advancements in the nanotechnology applications of today’s medical field.
Dr. Daniel Boon Loong Teh
Prof. Dr. Jinliang Liu
Prof. Dr. Mônica Villa Nova
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Micromachines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Nanoparticles
- Nanotechnology
- Nano-carriers
- Nano-vesicles
